• Sectors
    • Tech
    • Healthcare
    • Consumer
    • Energy
    • Mining & Metals
    • Business Services
    • Financials
    • Telecom
    • Industrials
    • Transportation
    • Aerospace & Defense
    • Real Estate
    • Utilities
  • Spotlight Stocks
  • CEO Interview
    • Investor Presentations
  • Newsmakers
  • Investing Strategy
    • Investment Research – Sponsored Reports
    • Analyst Reports
    • Insider Trading
    • Smart Money
  • Funds & ETF’s
  • Markets
    • Commodities
    • Currencies
    • Economy
    • Lending & Interest Rates
  • Business News
    • Trading Ideas
  • Executive Resources
    • Leadership & Strategy
    • Capital
    • Law
  • Investor Education
    • Long Term Investing
    • Personal Finance
    • Stock Trading
    • Options Trading
    • Forex Trading
    • Futures Trading
  • Members
  • EVENTS
    • Next Super Stock LIVE! – The Online Investor Conference
Newswire
  • [ January 20, 2020 ] Samsung Electronics appoints new mobile chief Business News
  • [ January 20, 2020 ] Guoxuan says in talks with Volkswagen, hasn’t reached binding agreement Business News
  • [ January 20, 2020 ] Asia shares camp on high ground, oil up on Libya shutdown Business News
  • [ January 20, 2020 ] Asia shares camp on high ground, oil up on Libya shutdown Trading Ideas
  • [ January 20, 2020 ] Oil Jumps After Unrest Hits Key OPEC Producers Libya and Iraq Trading Ideas
  • [ January 20, 2020 ] A thousand EU financial firms plan to open UK offices after Brexit Business News
  • [ January 20, 2020 ] Airbus unit to offer product to help airlines with revenue volatility Business News
  • [ January 20, 2020 ] IEA warns oil companies doing nothing on emissions is not an option Business News
  • [ January 20, 2020 ] Is This The End For Big Oil Dividends? Trading Ideas
  • [ January 20, 2020 ] What Does the Phase One Deal Mean for U.S. Energy Industry? Trading Ideas
HomeHealthcareHow to Trade Biotech and Pharmaceutical Stocks

How to Trade Biotech and Pharmaceutical Stocks

March 11, 2018 admin Healthcare, Investor Education Comments Off on How to Trade Biotech and Pharmaceutical Stocks

How to Trade Biotech and Pharmaceutical Stocks
Profiting from the FDA approval cycle

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati




Previous

Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib

Next

Rick Rule on Gold and Contrarian Stock Picks for 2018

Featured Stocks

newsmakers

  • CytoDyn (OTC: CYDY) Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab for the Treatment of Metastatic Triple-Negative Breast Cancer
    January 13, 2020 Comments Off on CytoDyn (OTC: CYDY) Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab for the Treatment of Metastatic Triple-Negative Breast Cancer
  • CytoDyn (OTC: CYDY) to Deliver Presentation at Biotech Showcase Conference
    January 10, 2020 Comments Off on CytoDyn (OTC: CYDY) to Deliver Presentation at Biotech Showcase Conference
  • NexTech (OTC: NEXCF) Reports Record Revenue and Gross Profit for Q4
    January 7, 2020 Comments Off on NexTech (OTC: NEXCF) Reports Record Revenue and Gross Profit for Q4
  • Nightfood (OTC: NGTF) Continues Hotel Expansion, Will Exhibit at the Hotel Supply Show of the Southeast
    January 6, 2020 Comments Off on Nightfood (OTC: NGTF) Continues Hotel Expansion, Will Exhibit at the Hotel Supply Show of the Southeast
  • NexTech (OTC: NEXCF) Signs Web-AR Deal With E-comm Site Weby Corp
    December 31, 2019 Comments Off on NexTech (OTC: NEXCF) Signs Web-AR Deal With E-comm Site Weby Corp
  • CytoDyn (OTC: CYDY) Reports Early, But Strong Positive Clinical Responses for Two Patients, One in Metastatic Breast Cancer and One in Metastatic Triple-Negative Breast Cancer Trials
    December 23, 2019 Comments Off on CytoDyn (OTC: CYDY) Reports Early, But Strong Positive Clinical Responses for Two Patients, One in Metastatic Breast Cancer and One in Metastatic Triple-Negative Breast Cancer Trials

CEO Interview

  • Nightfood (OTC: NGTF) Multi-billion dollar upside in “owning the night time snacking category”
    December 18, 2019 Comments Off on Nightfood (OTC: NGTF) Multi-billion dollar upside in “owning the night time snacking category”
  • Medicine Man Technologies (OTC: MDCL) $170 Million Cannabis Powerhouse – Update on Acquisitions & More.
    November 6, 2019 Comments Off on Medicine Man Technologies (OTC: MDCL) $170 Million Cannabis Powerhouse – Update on Acquisitions & More.
  • NexTech AR Solutions, Inc. (OTC: NEXCF) AR Technologies Targeting Billion Dollar Market Opportunities
    October 30, 2019 Comments Off on NexTech AR Solutions, Inc. (OTC: NEXCF) AR Technologies Targeting Billion Dollar Market Opportunities
LEADERS

Phunware, Inc. (NASDAQ: PHUN): Next $100 Billion Company of Decentralized Computing era?

CytoDyn Inc. (OTC: CYDY) HIV therapy nearing FDA approval + drug pipeline with blockbuster potential

Chatham Rock Phosphate Limited (TSX.V: NZP) “Hundred Bagger” upside potential

The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) Building brands “At the intersection of cannabis & wellness”

GP Solutions (OTC: GWPD) Indoor organic farming tech innovation addressing billion dollar markets

CytoDyn (OTC: CYDY) Monoclonal antibody HIV treatment w potential FDA approval in 2019

Medicine Man Technologies (OTC: MDCL) Vertically integrated cannabis operator, with growing revenues and profits

Cobalt27 (TSX.V: KBLT) (OTC: CBLLF) A “pure play” on electric vehicle boom

CytoDyn Inc. (OTC: CYDY) Monoclonal antibody for treating HIV and Cancer. Potential FDA approval for HIV in 2019

Elixinol Global Limited (ASX: EXL) (OTC: ELLXF) Emerging leader in CBD and Hemp foods and consumer products

  • Contact
  • About Us
  • Investor Relations Services
  • Terms of Use/Legal Notice
  • Become a Newsmaker
  • Login
  • Newsmakers Account
    • Subscriptions
    • Submit Press Release

Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.